DTR — Diagnostear Technologies Cashflow Statement
0.000.00%
- CA$19.16m
- CA$18.01m
Annual cashflow statement for Diagnostear Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1.19 | -1.15 | -16 | -3.32 |
| Depreciation | ||||
| Non-Cash Items | 0.459 | 0.12 | 14.5 | 1.15 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | — | — | -0.14 |
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0.728 | -1.03 | -1.5 | -2.22 |
| Capital Expenditures | -0.028 | -0.515 | 0 | 0 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -0.01 | 0 | 0.178 | -0.35 |
| Sale of Fixed Assets | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.038 | -0.515 | 0.178 | -0.35 |
| Financing Cash Flow Items | — | — | 3.31 | 0.059 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.373 | 1.73 | 3.64 | 0.987 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.421 | 0.177 | 2.2 | -1.52 |